Shi-Ying Lu Hui-Fang Yang Qing-Li Zeng Peng Chen Li Chen Jing Gao Xue-Kui Gu Hai Lan Man Luo
10.3389/fimmu.2023.1193808
Front Immunol
2023 Jun 5;14:1193808.
brentuximab vedotin drug-induced sweet syndrome granulocyte colony-stimulating factor local sinus ulcer systemic anaplastic large-cell lymphoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/37342351/
Fistula Immunoconjugates / therapeutic use Lymphoma, Large-Cell, Anaplastic / chemically induced Lymphoma, Large-Cell, Anaplastic / drug therapy Lymphoma, Large-Cell, Anaplastic / pathology Sweet Syndrome / chemically induced Sweet Syndrome / diagnosis Sweet Syndrome / drug therapy
Fistula Immunoconjugates / therapeutic use Lymphoma, Large-Cell, Anaplastic / chemically induced Lymphoma, Large-Cell, Anaplastic / drug therapy Lymphoma, Large-Cell, Anaplastic / pathology Sweet Syndrome / chemically induced Sweet Syndrome / diagnosis Sweet Syndrome / drug therapy Case Reports Brentuximab Vedotin / therapeutic use Fever / drug therapy Granulocyte Colony-Stimulating Factor Humans Male Immunoconjugates Brentuximab Vedotin Granulocyte Colony-Stimulating Factor
PMC10277476
37342351
Atypical Sweet syndrome: skin sinus tracts in an acutely febrile patient after lymphoma treatment: a case report
2023